Kratom Research Institute

Research · 2026-01-01

Lab Analysis Finds Products Sold as "Kratom Extract" Are Actually Synthetic 7-OH Drugs

Source: Journal of AOAC International

Why it matters

Consumers buying products labeled as "kratom extract" may unknowingly be ingesting high-dose synthetic opioid compounds — not the natural kratom leaf they believe they are purchasing. This distinction has direct implications for safety, regulation, and the ongoing federal scheduling debate.

The big picture

The sharp line between whole-leaf kratom and concentrated 7-hydroxymitragynine has become central to federal policy. DEA issued a temporary Schedule I order for high-concentration 7-OH in July 2026, and HHS opened a public comment docket that closes July 31. This study, using validated AOAC analytical methods, provides hard chemical evidence that many "kratom extract" products are not kratom at all — they are synthetic derivatives.

Key findings

What they say

The researchers stated: "These products differ significantly from authentic native kratom leaf and are not kratom extracts, as labeled, but rather synthetic derivatives that constitute unapproved new drugs being unlawfully marketed. There is an urgent need to differentiate kratom, which has been safely consumed for centuries, from 7-hydroxymitragynine, which may pose a significant risk to public health."

Bottom line

Products marketed as "kratom extract" routinely contain synthetic 7-OH at concentrations far above label claims, with no resemblance to authentic kratom leaf — making them unapproved drugs, not dietary supplements.